Developing Picornaviruses for Cancer Therapy
Oncolytic viruses (OVs) form a group of novel anticancer therapeutic agents which selectively infect and lyse cancer cells. Members of several viral families, including <i>Picornaviridae</i>,<i> </i>have been shown to have anticancer activity. Picornaviruses are small icosahe...
Main Authors: | Cormac McCarthy, Nadishka Jayawardena, Laura N. Burga, Mihnea Bostina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/685 |
Similar Items
-
Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA
by: Noura B. Elsedawy, et al.
Published: (2020-06-01) -
Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy
by: William J. Burnett, et al.
Published: (2021-09-01) -
Prediction of interacting motifs within the protein subunits of Picornavirus capsids
by: Ross, Caroline Jane
Published: (2015) -
Diverse Strategies Used by Picornaviruses to Escape Host RNA Decay Pathways
by: Wendy Ullmer, et al.
Published: (2016-12-01) -
Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges
by: Huitao Liu, et al.
Published: (2021-06-01)